feed,title,long_url,short_url
Benzinga,U.S. FDA Accepts Acadia's Filing For Rett Syndrome Candidate Under Priority Review,https://benzinga.com/news/22/09/28829615/u-s-fda-accepts-acadias-filing-for-rett-syndrome-candidate-under-priority-review,https://bit.ly/3B1Cha4
Benzinga,"Exelixis' XL092/ Atezolizumab Shows Encouraging Efficacy, Safety In Heavily Pretreated Cancer Patients",https://benzinga.com/general/biotech/22/09/28829547/exelixis-xl092-atezolizumab-shows-encouraging-efficacy-safety-in-heavily-pretreated-cancer-patien,https://bit.ly/3L6U5W0
